PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
^OEX vs. LLY
Performance
Risk-Adjusted Performance
Drawdowns
Volatility

Correlation

The correlation between ^OEX and LLY is 0.48, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.5

Performance

^OEX vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in S&P 100 Index (^OEX) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

-15.00%-10.00%-5.00%0.00%5.00%10.00%AugustSeptemberOctoberNovemberDecember2025
13.58%
-12.05%
^OEX
LLY

Key characteristics

Sharpe Ratio

^OEX:

2.11

LLY:

0.66

Sortino Ratio

^OEX:

2.79

LLY:

1.12

Omega Ratio

^OEX:

1.39

LLY:

1.15

Calmar Ratio

^OEX:

3.02

LLY:

0.85

Martin Ratio

^OEX:

12.77

LLY:

2.10

Ulcer Index

^OEX:

2.33%

LLY:

9.87%

Daily Std Dev

^OEX:

14.12%

LLY:

31.25%

Max Drawdown

^OEX:

-61.31%

LLY:

-68.27%

Current Drawdown

^OEX:

-0.21%

LLY:

-21.33%

Returns By Period

In the year-to-date period, ^OEX achieves a 2.83% return, which is significantly higher than LLY's -2.33% return. Over the past 10 years, ^OEX has underperformed LLY with an annualized return of 12.69%, while LLY has yielded a comparatively higher 28.96% annualized return.


^OEX

YTD

2.83%

1M

1.00%

6M

13.58%

1Y

29.15%

5Y*

15.13%

10Y*

12.69%

LLY

YTD

-2.33%

1M

-5.31%

6M

-12.05%

1Y

20.52%

5Y*

42.25%

10Y*

28.96%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

^OEX vs. LLY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

^OEX
The Risk-Adjusted Performance Rank of ^OEX is 9191
Overall Rank
The Sharpe Ratio Rank of ^OEX is 9191
Sharpe Ratio Rank
The Sortino Ratio Rank of ^OEX is 8989
Sortino Ratio Rank
The Omega Ratio Rank of ^OEX is 9494
Omega Ratio Rank
The Calmar Ratio Rank of ^OEX is 8686
Calmar Ratio Rank
The Martin Ratio Rank of ^OEX is 9595
Martin Ratio Rank

LLY
The Risk-Adjusted Performance Rank of LLY is 6767
Overall Rank
The Sharpe Ratio Rank of LLY is 6969
Sharpe Ratio Rank
The Sortino Ratio Rank of LLY is 6262
Sortino Ratio Rank
The Omega Ratio Rank of LLY is 6161
Omega Ratio Rank
The Calmar Ratio Rank of LLY is 7676
Calmar Ratio Rank
The Martin Ratio Rank of LLY is 6767
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

^OEX vs. LLY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for S&P 100 Index (^OEX) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ^OEX, currently valued at 2.11, compared to the broader market-0.500.000.501.001.502.002.502.110.66
The chart of Sortino ratio for ^OEX, currently valued at 2.79, compared to the broader market0.001.002.003.002.791.12
The chart of Omega ratio for ^OEX, currently valued at 1.39, compared to the broader market1.001.201.401.601.391.15
The chart of Calmar ratio for ^OEX, currently valued at 3.02, compared to the broader market0.001.002.003.003.020.85
The chart of Martin ratio for ^OEX, currently valued at 12.77, compared to the broader market0.005.0010.0015.0020.0012.772.10
^OEX
LLY

The current ^OEX Sharpe Ratio is 2.11, which is higher than the LLY Sharpe Ratio of 0.66. The chart below compares the historical Sharpe Ratios of ^OEX and LLY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00AugustSeptemberOctoberNovemberDecember2025
2.11
0.66
^OEX
LLY

Drawdowns

^OEX vs. LLY - Drawdown Comparison

The maximum ^OEX drawdown since its inception was -61.31%, smaller than the maximum LLY drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for ^OEX and LLY. For additional features, visit the drawdowns tool.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-0.21%
-21.33%
^OEX
LLY

Volatility

^OEX vs. LLY - Volatility Comparison

The current volatility for S&P 100 Index (^OEX) is 4.63%, while Eli Lilly and Company (LLY) has a volatility of 10.58%. This indicates that ^OEX experiences smaller price fluctuations and is considered to be less risky than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%AugustSeptemberOctoberNovemberDecember2025
4.63%
10.58%
^OEX
LLY
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab